Reeve B Waud's most recent trade in Acadia Healthcare Company Inc was a trade of 10,637 Common Stock done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 10,637 | 59,952 (0%) | 0% | 0 | Common Stock | |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 7,032 | 49,315 (0%) | 0% | 0 | Common Stock | |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 3,651 | 42,283 (0%) | 0% | 0 | Common Stock | |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 2,414 | 38,632 (0%) | 0% | 0 | Common Stock | |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Grant, award, or other acquisition of securities at price $ 73.02 per share. | 10 Nov 2023 | 68,028 | 653,015 (0%) | 0% | 73.0 | 4,967,405 | Common Stock, par value $0.01 per share |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Grant, award, or other acquisition of securities at price $ 71.78 per share. | 18 May 2023 | 3,371 | 36,218 (0%) | 0% | 71.8 | 241,970 | Common Stock, par value $0.01 per share |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 2,229 | 32,847 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 2,303 | 30,618 (0%) | 0% | 0 | Common Stock | |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Sale of securities on an exchange or to another person at price $ 66.47 per share. | 14 Jun 2021 | 27,515 | 506,844 (0%) | 0% | 66.5 | 1,828,922 | Common Stock, par value $0.01 per share |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Sale of securities on an exchange or to another person at price $ 66.47 per share. | 14 Jun 2021 | 27,515 | 534,359 (0%) | 0% | 66.5 | 1,828,922 | Common Stock, par value $0.01 per share |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 2,550 | 28,315 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Acadia Healthcare Company Inc | Reeve B. Waud | Director | Sale of securities on an exchange or to another person at price $ 59.12 per share. | 12 Mar 2021 | 109,443 | 561,874 (0%) | 0% | 59.1 | 6,470,358 | Common Stock, par value $0.01 per share |